ATE420162T1 - Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen - Google Patents

Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen

Info

Publication number
ATE420162T1
ATE420162T1 AT03788380T AT03788380T ATE420162T1 AT E420162 T1 ATE420162 T1 AT E420162T1 AT 03788380 T AT03788380 T AT 03788380T AT 03788380 T AT03788380 T AT 03788380T AT E420162 T1 ATE420162 T1 AT E420162T1
Authority
AT
Austria
Prior art keywords
methods
compositions
secretory lysosomes
targeting
lysosomes
Prior art date
Application number
AT03788380T
Other languages
English (en)
Inventor
Daniel Rajotte
Alisa Kabcenell
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE420162T1 publication Critical patent/ATE420162T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/055—Fusion polypeptide containing a localisation/targetting motif containing a signal for localisation to secretory granules (for exocytosis)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT03788380T 2002-08-14 2003-08-12 Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen ATE420162T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40346402P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
ATE420162T1 true ATE420162T1 (de) 2009-01-15

Family

ID=31888238

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03788380T ATE420162T1 (de) 2002-08-14 2003-08-12 Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen

Country Status (9)

Country Link
US (3) US20040082017A1 (de)
EP (1) EP1532239B1 (de)
JP (1) JP2005538707A (de)
AT (1) ATE420162T1 (de)
AU (1) AU2003259750A1 (de)
CA (1) CA2493822C (de)
DE (1) DE60325737D1 (de)
ES (1) ES2318187T3 (de)
WO (1) WO2004016212A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425426B2 (en) * 2004-03-15 2008-09-16 Cyntellect, Inc. Methods for purification of cells based on product secretion
WO2006115234A1 (ja) * 2005-04-21 2006-11-02 Nisshin Seifun Group Inc. アレルギー原因物質の検出方法およびアレルギー抑制剤のスクリーニング方法
US8788213B2 (en) 2009-01-12 2014-07-22 Intrexon Corporation Laser mediated sectioning and transfer of cell colonies
CA2806294C (en) 2010-07-28 2018-06-12 Canvax Biotech Sl Novel ultrasensitive cell based sensors and uses thereof
WO2013025598A1 (en) * 2011-08-12 2013-02-21 The Children's Hospital Of Philadelphia Degranulation indicator and methods of use thereof
CN116855503B (zh) * 2023-08-30 2023-12-08 上海益诺思生物技术股份有限公司 过表达mrgprx2的稳转细胞株及其构建方法和应用

Also Published As

Publication number Publication date
CA2493822A1 (en) 2004-02-26
EP1532239A2 (de) 2005-05-25
ES2318187T3 (es) 2009-05-01
CA2493822C (en) 2013-02-26
DE60325737D1 (de) 2009-02-26
AU2003259750A8 (en) 2004-03-03
WO2004016212A3 (en) 2004-09-02
US20070161054A1 (en) 2007-07-12
JP2005538707A (ja) 2005-12-22
US20040082017A1 (en) 2004-04-29
US20090203026A1 (en) 2009-08-13
AU2003259750A1 (en) 2004-03-03
EP1532239A4 (de) 2007-06-20
EP1532239B1 (de) 2009-01-07
WO2004016212A2 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
HRP20181459T1 (hr) Humanizirani antagonisti anti-beta7 i njihove uporabe
SE0301653D0 (sv) Novel compounds
ATE501268T1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
IL209338A0 (en) Pharmaceutical compositions containing anti-cd-3 antibodies
MXPA03007413A (es) Composicion y metodo para tratar enfermedades inflamatorias.
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ATE463479T1 (de) D-homoandrosta-17-yl-carbamat-derivate als selektive glucocorticoid-rezeptor-liganden
EA200700654A1 (ru) Способ очистки глины
ATE505538T1 (de) Dna-vektoren
ATE425212T1 (de) Tocopherolzusammensetzungen und verwendung
MY142798A (en) Methods for preventing glyconoylation of proteins
ATE546157T1 (de) Anti-pecam-therapie zur unterdrückung von metastasen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1532239

Country of ref document: EP